Ksiazek A, Baranowska-Daca E
Nephrology Department, Medical Academy of Lublin, Poland.
Perit Dial Int. 1993;13 Suppl 2:S550-2.
Seven intermittent peritoneal dialysis (IPD) patients were investigated before and after correction of anemia with recombinant human erythropoietin (r-HuEPO). When hematocrit exceeded 30%, the peritoneal equilibration test was performed at 1, 2, 4, 8 hours. Correction of anemia was associated with a mean value increment in creatinine and phosphate clearance in 1- and 2-hour dwells. Differences in clearance of sodium, potassium, and urea in protein loss and glucose absorption before and after r-HuEPO therapy were not statistically significant. Increased creatinine and phosphate clearance during short dwells can be effected in IPD patients.
对7例间歇性腹膜透析（IPD）患者在使用重组人促红细胞生成素（r-HuEPO）纠正贫血前后进行了研究。当血细胞比容超过30%时，在1、2、4、8小时进行腹膜平衡试验。贫血的纠正与1小时和2小时留腹时肌酐和磷酸盐清除率的平均值增加有关。r-HuEPO治疗前后钠、钾、尿素清除率、蛋白质丢失和葡萄糖吸收的差异无统计学意义。IPD患者在短时间留腹时可实现肌酐和磷酸盐清除率的增加。
